梅花生物（600873）8月13日主力资金净流入1297.70万元

Group 1 - The core viewpoint of the news is that Meihua Biological (600873) has shown a mixed performance in its latest financial results, with a decrease in total revenue but a significant increase in net profit [1] - As of August 13, 2025, the stock price of Meihua Biological closed at 11.01 yuan, reflecting a slight increase of 0.18% [1] - The company reported total revenue of 6.269 billion yuan for Q1 2025, a year-on-year decrease of 3.36%, while net profit attributable to shareholders was 1.019 billion yuan, a year-on-year increase of 35.52% [1] Group 2 - The company has a current ratio of 1.359 and a quick ratio of 0.920, indicating its liquidity position [1] - Meihua Biological has a debt-to-asset ratio of 36.41%, suggesting a moderate level of financial leverage [1] - The company has made investments in 20 enterprises and participated in 73 bidding projects, showcasing its active engagement in business expansion [2]